20-1537268-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_178460.3(SIRPD):c.464C>A(p.Ala155Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000372 in 1,614,002 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_178460.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SIRPD | NM_178460.3 | c.464C>A | p.Ala155Glu | missense_variant | 3/4 | ENST00000381623.4 | NP_848555.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SIRPD | ENST00000381623.4 | c.464C>A | p.Ala155Glu | missense_variant | 3/4 | 1 | NM_178460.3 | ENSP00000371036.3 | ||
SIRPD | ENST00000381621.5 | c.467C>A | p.Ala156Glu | missense_variant | 3/4 | 3 | ENSP00000371034.1 | |||
SIRPD | ENST00000429387.5 | c.110C>A | p.Ala37Glu | missense_variant | 2/3 | 3 | ENSP00000410072.1 | |||
ENSG00000242324 | ENST00000453770.1 | n.803-3474C>A | intron_variant | 6 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152142Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251206Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135728
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461860Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 727232
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152142Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74318
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2024 | The c.464C>A (p.A155E) alteration is located in exon 3 (coding exon 3) of the SIRPD gene. This alteration results from a C to A substitution at nucleotide position 464, causing the alanine (A) at amino acid position 155 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at